Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
|
US |
|
C
|
CME Group Inc
LSE:0HR2
|
US |
|
Broadcom Inc
NASDAQ:AVGO
|
US |
|
Cromwell Property Group
OTC:CMWCF
|
AU |
|
B
|
BNP Paribas SA
XETRA:BNP
|
FR |
|
Tradeweb Markets Inc
NASDAQ:TW
|
US |
|
Netcall PLC
OTC:NCLLF
|
UK |
|
I
|
Innate Pharma SA
OTC:IPHYF
|
FR |
|
Ascendis Pharma A/S
NASDAQ:ASND
|
DK |
|
Sojitz Corp
TSE:2768
|
JP |
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
US |
|
New Palace International Co Ltd
TWSE:8940
|
TW |
|
Sietel Ltd
ASX:SSL
|
AU |
|
Equinor ASA
OTC:STOHF
|
NO |
|
King Wan Corp Ltd
SGX:554
|
SG |
|
K
|
Kinder Morgan Inc
XMUN:2KD
|
US |
|
Bioventix PLC
LSE:BVXP
|
UK |
|
F
|
Fuji Electric Co Ltd
XMUN:FJE
|
JP |
|
Lineage Inc
NASDAQ:LINE
|
US |
|
Cashmere Valley Bank
OTC:CSHX
|
US |
|
C
|
Cohort PLC
F:C7K
|
UK |
|
Sailor Pen Co Ltd
TSE:7992
|
JP |
|
A
|
Autoliv Inc
DUS:LIV
|
SE |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
US |
Bankruptcy Probability
Syndax Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Syndax Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
|
1.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Syndax Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Syndax Pharmaceuticals Inc has total debt of 588.1m USD. This includes both short-term (0 USD) and long-term (588.1m USD) debt.
You can find a full breakdown on its Balance Sheet.